Gerald E. Quirk - Oct 11, 2022 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SYRS	Restricted Stock Units	Award	$0	+45K		$0.00	45K	Oct 11, 2022	Common Stock	45K		Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
F2	These RSUs will vest as to one half (50%) of the shares on October 11, 2023, and as to one half (50%) of the shares on March 31, 2024.